Long-Term Estrogen Therapy Improves Vascular Function in Male to Female Transsexuals

AbstractObjectives. This study sought to examine the effects of long-term estrogen therapy on vascular function in male to female transsexuals and to compare the findings with those observed in men and premenopausal women.Background. Gender differences in coronary artery disease have largely been attributed to the beneficial effects of estrogen on vascular function and plasma lipids in women. However, the effects of estrogen on the male vasculature have not been widely studied.Methods. We compared the effects of estrogen on vascular function in 14 male to female transsexuals, 14 age-matched men and 15 premenopausal women. Flow-mediated vasodilation and response to nitroglycerin were assessed in the brachial artery using noninvasive ultrasound.Results. Flow-mediated vasodilation was similar in transsexuals and women but greater than that in men ([mean ± SE] 11.5 ± 1.3% and 9.4 ± 1.1% vs. 5.2 ± 1.0% respectively, p < 0.005). Responses to nitroglycerin were also greater in transsexuals and women than in men (21.6 ± 1.7% and 21.0 ± 0.9% vs. 14.5 ± 1.2%, respectively, p = 0.0005). These differences persisted even after adjusting for vessel size. Despite similar total cholesterol levels, transsexuals had high density lipoprotein cholesterol levels similar to those in women and greater than those observed in men (1.76 ± 0.12 and 1.82 ± 0.11 mmol/liter vs. 1.35 ± 0.07 mmol/liter, respectively, p < 0.005). Moreover, triglyceride levels were greater in transsexuals than in men and women, and low density lipoprotein cholesterol (LDL-C) particle size was smaller (25.7 ± 0.2 nm vs. 26.2 ± 0.1 and 26.6 ± 0.1 nm, respectively, p = 0.0001). Serum testosterone (an index of estrogen therapy in transsexuals) was markedly suppressed in transsexuals and similar to that in women. Univariate analysis revealed that there was a strong inverse correlation between serum testosterone and flow-mediated vasodilation (rs= −0.48, p < 0.005). Multivariate analysis revealed that the best combination of predictors of flow-mediated vasodilation was serum testosterone, vessel size and LDL-C (R2= 0.3, p < 0.005).Conclusions. Long-term estrogen therapy appears to improve vascular function in male to female transsexuals and occurs despite higher triglyceride levels and the presence of small, dense LDL-C. The beneficial effects of estrogen are not gender specific or solely mediated through endothelium-derived nitric oxide.(J Am Coll Cardiol 1997;29:1437–44

User Selection Approaches to Mitigate the Straggler Effect for Federated Learning on Cell-Free Massive MIMO Networks

This work proposes UE selection approaches to mitigate the straggler effect for federated learning (FL) on cell-free massive multiple-input multiple-output networks. To show how these approaches work, we consider a general FL framework with UE sampling, and aim to minimize the FL training time in this framework. Here, training updates are (S1) broadcast to all the selected UEs from a central server, (S2) computed at the UEs sampled from the selected UE set, and (S3) sent back to the central server. The first approach mitigates the straggler effect in both Steps (S1) and (S3), while the second approach only Step (S3). Two optimization problems are then formulated to jointly optimize UE selection, transmit power and data rate. These mixed-integer mixed-timescale stochastic nonconvex problems capture the complex interactions among the training time, the straggler effect, and UE selection. By employing the online successive convex approximation approach, we develop a novel algorithm to solve the formulated problems with proven convergence to the neighbourhood of their stationary points. Numerical results confirm that our UE selection designs significantly reduce the training time over baseline approaches, especially in the networks that experience serious straggler effects due to the moderately low density of access points.Comment: submitted for peer review

PALEO-PGEM v1.0: a statistical emulator of Pliocene–Pleistocene climate

We describe the development of the “Paleoclimate PLASIM-GENIE (Planet Simulator–Grid-Enabled Integrated Earth system model) emulator” PALEO-PGEM and its application to derive a downscaled high-resolution spatio-temporal description of the climate of the last 5×106 years. The 5×106-year time frame is interesting for a range of paleo-environmental questions, not least because it encompasses the evolution of humans. However, the choice of time frame was primarily pragmatic; tectonic changes can be neglected to first order, so that it is reasonable to consider climate forcing restricted to the Earth's orbital configuration, ice-sheet state, and the concentration of atmosphere CO2. The approach uses the Gaussian process emulation of the singular value decomposition of ensembles of the intermediate-complexity atmosphere–ocean GCM (general circulation model) PLASIM-GENIE. Spatial fields of bioclimatic variables of surface air temperature (warmest and coolest seasons) and precipitation (wettest and driest seasons) are emulated at 1000-year intervals, driven by time series of scalar boundary-condition forcing (CO2, orbit, and ice volume) and assuming the climate is in quasi-equilibrium. Paleoclimate anomalies at climate model resolution are interpolated onto the observed modern climatology to produce a high-resolution spatio-temporal paleoclimate reconstruction of the Pliocene–Pleistocene

Interim-treatment quantitative PET parameters predict progression and death among patients with hodgkin's disease

PURPOSE: We hypothesized that quantitative PET parameters may have predictive value beyond that of traditional clinical factors such as the International Prognostic Score (IPS) among Hodgkin's disease (HD) patients. METHODS: Thirty HD patients treated at presentation or relapse had staging and interim-treatment PET-CT scans. The majority of patients (53%) had stage III-IV disease and 67% had IPS ≥ 2. Interim-treatment scans were performed at a median of 55 days from the staging PET-CT. Chemotherapy regimens used: Stanford V (67%), ABVD (17%), VAMP (10%), or BEACOPP (7%). Hypermetabolic tumor regions were segmented semiautomatically and the metabolic tumor volume (MTV), mean standardized uptake value (SUVmean), maximum SUV (SUVmax) and integrated SUV (iSUV) were recorded. We analyzed whether IPS, absolute value PET parameters or the calculated ratio of interim- to pre-treatment PET parameters were associated with progression free survival (PFS) or overall survival (OS). RESULTS: Median follow-up of the study group was 50 months. Six of the 30 patients progressed clinically. Absolute value PET parameters from pre-treatment scans were not significant. Absolute value SUVmax from interim-treatment scans was associated with OS as determined by univariate analysis (p < 0.01). All four calculated PET parameters (interim/pre-treatment values) were associated with OS: MTV(int/pre )(p < 0.01), SUVmean(int/pre )(p < 0.05), SUVmax(int/pre )(p = 0.01), and iSUV(int/pre )(p < 0.01). Absolute value SUVmax from interim-treatment scans was associated with PFS (p = 0.01). Three calculated PET parameters (int/pre-treatment values) were associated with PFS: MTV(int/pre )(p = 0.01), SUVmax(int/pre )(p = 0.02) and iSUV(int/pre )(p = 0.01). IPS was associated with PFS (p < 0.05) and OS (p < 0.01). CONCLUSIONS: Calculated PET metrics may provide predictive information beyond that of traditional clinical factors and may identify patients at high risk of treatment failure early for treatment intensification

Astrocytic glutamate transport regulates a Drosophila CNS synapse that lacks astrocyte ensheathment.

Anatomical, molecular, and physiological interactions between astrocytes and neuronal synapses regulate information processing in the brain. The fruit fly Drosophila melanogaster has become a valuable experimental system for genetic manipulation of the nervous system and has enormous potential for elucidating mechanisms that mediate neuron-glia interactions. Here, we show the first electrophysiological recordings from Drosophila astrocytes and characterize their spatial and physiological relationship with particular synapses. Astrocyte intrinsic properties were found to be strongly analogous to those of vertebrate astrocytes, including a passive current-voltage relationship, low membrane resistance, high capacitance, and dye-coupling to local astrocytes. Responses to optogenetic stimulation of glutamatergic premotor neurons were correlated directly with anatomy using serial electron microscopy reconstructions of homologous identified neurons and surrounding astrocytic processes. Robust bidirectional communication was present: neuronal activation triggered astrocytic glutamate transport via excitatory amino acid transporter 1 (Eaat1), and blocking Eaat1 extended glutamatergic interneuron-evoked inhibitory postsynaptic currents in motor neurons. The neuronal synapses were always located within 1 μm of an astrocytic process, but none were ensheathed by those processes. Thus, fly astrocytes can modulate fast synaptic transmission via neurotransmitter transport within these anatomical parameters. J. Comp. Neurol. 524:1979-1998, 2016. © 2016 Wiley Periodicals, Inc.This is the author accepted manuscript. The final version is available from Wiley via http://dx.doi.org/10.1002/cne.2401

Nanoparticle-Delivered Multimeric Soluble CD40L DNA Combined with Toll-Like Receptor Agonists as a Treatment for Melanoma

Stimulation of CD40 or Toll-Like Receptors (TLR) has potential for tumor immunotherapy. Combinations of CD40 and TLR stimulation can be synergistic, resulting in even stronger dendritic cell (DC) and CD8+ T cell responses. To evaluate such combinations, established B16F10 melanoma tumors were injected every other day X 5 with plasmid DNA encoding a multimeric, soluble form of CD40L (pSP-D-CD40L) either alone or combined with an agonist for TLR1/2 (Pam3CSK4 ), TLR2/6 (FSL-1 and MALP2), TLR3 (polyinosinic-polycytidylic acid, poly(I:C)), TLR4 ( monophosphoryl lipid A, MPL), TLR7 (imiquimod), or TLR9 (Class B CpG phosphorothioate oligodeoxynucleotide, CpG). When used by itself, pSP-D-CD40L slowed tumor growth and prolonged survival, but did not lead to cure. Of the TLR agonists, CpG and poly(I:C) also slowed tumor growth, and the combination of these two TLR agonists was more effective than either agent alone. The triple combination of intratumoral pSP-D-CD40L + CpG + poly(I:C) markedly slowed tumor growth and prolonged survival. This treatment was associated with a reduction in intratumoral CD11c+ dendritic cells and an influx of CD8+ T cells. Since intratumoral injection of plasmid DNA does not lead to efficient transgene expression, pSP-D-CD40L was also tested with cationic polymers that form DNA-containing nanoparticles which lead to enhanced intratumoral gene expression. Intratumoral injections of pSP-D-CD40L-containing nanoparticles formed from polyethylenimine (PEI) or C32 (a novel biodegradable poly(B-amino esters) polymer) in combination with CpG + poly(I:C) had dramatic antitumor effects and frequently cured mice of B16F10 tumors. These data confirm and extend previous reports that CD40 and TLR agonists are synergistic and demonstrate that this combination of immunostimulants can significantly suppress tumor growth in mice. In addition, the enhanced effectiveness of nanoparticle formulations of DNA encoding immunostimulatory molecules such as multimeric, soluble CD40L supports the further study of this technology for tumor immunotherapy

Acoustofluidic closed-loop control of microparticles and cells using standing surface acoustic waves

Precise, automatic and reliable position control of micro-objects such as single particles, biological cells or bio-organisms is critical for applications in biotechnology and tissue engineering. However, conventional acoustofluidic techniques generally lack reliability and automation capability thus are often incapable of building an efficient and automated system where the biological cells need to be precisely manipulated in three dimensions (3D). To overcome these limitations, we developed an acoustofluidic closed-loop control system which is combined with computer vision techniques and standing surface acoustic waves (SSAWs) to implement selective, automatic and precise position control of an object, such as a single cell or microparticle in a microfluidic chamber. Position of the object is in situ extracted from living images that are captured from a video camera. By utilizing the closed-loop control strategy, the object is precisely moved to the desired location in 3D patterns or along designed trajectories by manipulating the phase angle and power signal of the SSAWs. Controlling of breast cancer cells has been conducted to verify the principle and biocompatibility of the control system. This system could be employed to build an automatic system for cell analysis, cell isolation, self-assembling of materials into complex microstructures, or lab-on-chip and organ-on-chip applications